Auckland City Hospital
Auckland City Hospital
Auckland, New Zealand23 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma | DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Tumor Virus Infections, adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, viral infectious disease | Active, not recruiting | Phase 2 | 2026-10-07 | NCT04291885 | |
| IKS014 in Advanced Solid Tumors That Express HER2 | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, skin disorder, stomach disorder | Recruiting | Phase 1 | 2026-09-28 | NCT05872295 | |
| A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure | Atrial Arrhythmia; Intracardiac Echocardiography | Recruiting | Not applicable | 2026-09-24 | NCT07353710 | |
| Canadian Critical Care Comparative Effectiveness Platform | Intensive Care Unit ICU; Nutrition; Platelet; Vasopressor | Recruiting | Phase 3 | 2026-09-22 | NCT06605144 | |
| A First in Human Study for the Versa Device for Tricuspid Regurgitation | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Active, not recruiting | Not applicable | 2026-08-28 | NCT06368401 | |
| A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 | 2026-08-28 | NCT04449874 | |
| The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study | Embolism and Thrombosis, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, Varicose Ulcer, Venous Thrombosis, cardiovascular disorder, skin disorder, thrombotic disease, varicose disease, vascular disorder, vein disorder | Active, not recruiting | Not applicable | 2026-08-27 | NCT05409976 | |
| Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, hyperphosphatemia, kidney disorder, kidney failure, metabolic disease, phosphorus metabolism disease, urinary system disorder | Recruiting | Not applicable | 2026-08-26 | NCT03573089 | |
| The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2026-05-13 | NCT05811364 | |
| Evaluation of a Simple-Prep Controlled Embolic | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Soft Tissue Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, angiomyolipoma, benign urinary system neoplasm, bone disorder, bone neoplasm, carcinoma, cardiovascular disorder, epithelial neoplasm, kidney angiomyolipoma, kidney cancer, kidney disorder, musculoskeletal system disorder, neoplasm, neoplasm with perivascular epithelioid cell differentiation, renal cell carcinoma, urinary system disorder, vascular disorder, vascular neoplasm | Active, not recruiting | Not applicable | 2026-03-30 | NCT06453642 | |
| Combination Immunotherapy in Rare Cancers Under InvesTigation | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, female reproductive system disorder, female reproductive system neoplasm, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-02-27 | NCT04969887 | |
| First-in-human Trial of Home Brain Pressure Measured Using Kitea ICP Sensor, Placed During Hydrocephalus Shunt Surgery. | brain disorder, central nervous system disorder, hydrocephalus, nervous system disorder | Active, not recruiting | Not applicable | 2026-02-13 | NCT06402786 | |
| First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA) | Aneurysm, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, vascular disorder | Active, not recruiting | Not applicable | 2025-12-16 | NCT05133492 | |
| First-In-Human Study Evaluating Aneurysm Sac Lining in AAA Patients | Aneurysm, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2025-12-09 | NCT07020611 | |
| Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, brain disorder, central nervous system cancer, central nervous system disorder, melanocytic neoplasm, melanoma, neoplasm, nervous system disorder, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 3 | 2025-09-24 | NCT04674683 | |
| Newborn Genomics Programme | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, hereditary disease | Recruiting | Not stated | 2025-05-07 | NCT06081075 | |
| Stepcare Extended Follow-up Substudy | Cognition Disorders, Cognitive Dysfunction, Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, central nervous system disorder, cognitive disorder, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2025-04-23 | NCT06207942 | |
| The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, coronary stenosis, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2025-03-24 | NCT04192747 | |
| Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2025-02-06 | NCT02446405 | |
| Zenith LAA Occlusion System | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2024-10-16 | NCT05951101 | |
| FA Clinical Outcome Measures | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Friedreich ataxia, Nutritional and Metabolic Diseases, Spinocerebellar Degenerations, brain disorder, central nervous system disorder, cerebellar disorder, hereditary disease, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, spinal cord disorder | Active, not recruiting | Not stated | 2024-10-04 | NCT03090789 | |
| Prostate Advances in Comparative Evidence | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2024-01-19 | NCT01584258 | |
| The Chocolate Touch Study | Arterial Occlusive Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not applicable | 2023-10-30 | NCT02924857 |